 Telegraph.co.uk | Biotech deals involve 3 firms in Bay Area Los Angeles Times, CA Shares of CV Therapeutics rocketed $5.04, or 32% to $21.04, while Gilead climbed 39 cents to $44.43. An index of 20 biotech stocks gained more than 6%. Genentech rose $1.75, or 1.9%, to $93.92. Roche's US-traded shares slipped 26 cents to $30.39. Genentech Deal Goes Down, Volatility Evaporates The Price of Friendship: For Genentech, It’s $95 a Share Roche, Genentech Finally Agree to Acquisition at $95 per Share |
Friday, March 13, 2009
Farmington NEWS - Biotech deals involve 3 firms in Bay Area - Los Angeles Times
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment